CAM
ATRA icon

Cormorant Asset Management’s Atara Biotherapeutics ATRA Stock Holding History

Cormorant Asset Management’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-12,000
Closed -$4.24M – 71
2019
Q3 		$4.24M Sell
12,000
-4,000
-25% -$1.49M 0.26% 58
2019
Q2 		$8.04M Sell
16,000
-6,000
-27% -$4.24M 0.46% 54
2019
Q1 		$21.9M Buy
+22,000
New +$20.4M 1.48% 26
2016
Q4 		– Sell
-7,458
Closed -$3.99M – 80
2016
Q3 		$3.99M Hold
7,458
– – 0.44% 57
2016
Q2 		$4.2M Buy
7,458
+1,458
+24% +$700K 0.6% 47
2016
Q1 		$2.85M Hold
6,000
– – 0.43% 55
2015
Q4 		$3.96M Hold
6,000
– – 0.47% 50
2015
Q3 		$4.72M Buy
6,000
+4,000
+200% +$4.88M 0.75% 38
2015
Q2 		$2.64M Buy
+2,000
New +$2.29M 0.35% 56

Other funds holding ATRA

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $718M AUM 8.19% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return